Strona główna

  • Banner

  • Reduced price
Hepatitis C Direct Acting Antivirals: The New Standard of Care, An Issue of Clinics in Liver Disease

Hepatitis C Direct Acting Antivirals: The New Standard of Care, An Issue of Clinics in Liver Disease

9781455711079
413,23 zł
351,25 zł Save 61,98 zł Tax included
Lowest price within 30 days before promotion: 351,25 zł
Quantity
Available in 4-6 weeks

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Description
Hepatitis C Virus is a quickly evolving area within hepatology owing to new medical therapies. This issue, guest edited by Dr. Fred Poordad, includes the most current clinical information and treatment therapies. Expert authors have written review articles devoted to the following medical therapies:: Boceprevir, Telaprevir, Protease Inhibitors in Development, NS5B Nucleoside and Non-Nucleoside Inhibitors. Review articles also address important patients like nadve- and non-responders and relapsers, the HIV co-infected patient, and the Genotype 1 and non-Genotype 1 patient.
Product Details
Saunders
50230
9781455711079
9781455711079

Data sheet

Rok wydania
2011
Numer wydania
1
Oprawa
twarda
Wymiary (mm)
152 x 229
Waga (g)
460
Comments (0)
Viewed products

  • Frequently purchased together

    No products available